Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7243 results

Sort By:

TRUDI: TDXD+Durva in HER2+/low IBC

Study ID: NCT05795101
Start Date: 2023-05-04
End Date: 2032-12-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

63

Intervention / Treatment

Trastuzumab deruxtecan

Durvalumab

Sponsor

Filip Lynce, MD

Source: clinicaltrials.gov

Share:
Add to list

A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides

Study ID: NCT05296304
Start Date: 2022-03-16
End Date: 2026-03
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

Bexarotene

Total Skin Electron Beam (TSEB)

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Telehealth Visits to Discuss Advanced Directives for Patients Newly Diagnosed With High Grade Glioma

Study ID: NCT04543201
Start Date: 2021-08-26
End Date: 2026-07-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Early START visit using checklist over telephone or zoom

Sponsor

University of Rochester

Source: clinicaltrials.gov

Share:
Add to list

Biomarker Monitoring of Prostate Cancer Patients With RSI MRI (ProsRSI)

Study ID: NCT04349501
Start Date: 2020-12-29
End Date: 2026-12-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

100

Intervention / Treatment

Restriction Spectrum Imaging Magnetic Resonance Imaging

Sponsor

University of California, San Diego

Source: clinicaltrials.gov

Share:
Add to list

Contrast-Enhanced Mammography for the Evaluation of Mammographic Microcalcifications

Study ID: NCT05046301
Start Date: 2021-03-23
End Date: 2027-02-02
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

151

Intervention / Treatment

Biospecimen Collection

Contrast Agent

Contrast-Enhanced Mammography

Administration questionnaire

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Study ID: NCT05366881
Start Date: 2022-05-03
End Date: 2026-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

7000

Intervention / Treatment
Sponsor

Adela, Inc

Source: clinicaltrials.gov

Share:
Add to list

Testing the Combination of Anti-cancer Drugs Atezolizumab and Tiragolumab in People With Advanced Stage Rare Cancers, RARE3 Trial

Study ID: NCT05715281
Start Date: 2023-09-26
End Date: 2026-10-15
Study Type

Interventional

Study Phase

Phase2

No. of Participants

15

Intervention / Treatment

Atezolizumab

Biopsy Procedure

Biospecimen Collection

Computed Tomography

Echocardiography Test

Tiragolumab

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer

Study ID: NCT06074510
Start Date: 2024-02-08
End Date: 2026-11
Study Type

Interventional

Study Phase

Phase4

No. of Participants

274

Intervention / Treatment

Piflufolastat F 18 Intravenous Solution [PYLARIFY]

Sponsor

Lantheus Medical Imaging

Source: clinicaltrials.gov

Share:
Add to list

A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing

Study ID: NCT06066138
Start Date: 2025-08-13
End Date: 2027-01-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

40

Intervention / Treatment

Atezolizumab

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer

Study ID: NCT05417308
Start Date: 2023-03-01
End Date: 2025-12-31
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

50

Intervention / Treatment

Minoxidil

Minoxidil

Quality-of-Life Assessment

Administration questionnaire

Sponsor

Ohio State University Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list